Difficult-to-wean patients: can we avoid the problem?

S. Nava (Bologna, Italy)

Source: ERS Skills Course 2016
Number: 2
Disease area: Respiratory critical care

PDF journal article, handout or slidesPDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Nava (Bologna, Italy). Difficult-to-wean patients: can we avoid the problem?. ERS Skills Course 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
TB in children: still a real problem?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012

Patients' perception of peakflowmeters use in Ukraine: does it pose an issue for asthma control?
Source: Eur Respir J 2002; 20: Suppl. 38, 540s
Year: 2002

How children with asthma breathe: have we been overlooking a problem?
Source: Eur Respir J 2013; 41: 1008-1009
Year: 2013

Practical approach to the difficult-to-wean patient: who, how and where?
Source: ERS Skills Course 2016
Year: 2016

MDR-/XDR-TB: what are the unresolved problems in the clinical management?
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012

Mandibular advancement: How do they work? How to sufficiently select patients?
Source: Sleep and Breathing Conference 2021
Year: 2021

The acute PE patient at high risk: how should we manage this patient?
Source: International Congress 2017 – From acute clots to chronic thromboembolic pulmonary hypertension
Year: 2017

Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018

What do patients expect from ERN-LUNG?
Source: International Congress 2018 – Rare lung diseases
Year: 2018

Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Steroids related tuberculosis: Does a subgroup require a more cautious approach?
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011

The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017

Pulmonary rehabilitation: can we identify the patients who will benefit most?
Source: Eur Respir J 2001; 18: Suppl. 33, 187s
Year: 2001

Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

Inhaler device handling: have we really started to address the problem?
Source: Eur Respir J , 49 (2) 1700120; DOI: 10.1183/13993003.00120-2017
Year: 2017

Managing difficult to treat P-NTM: boredom or challenge
Source: International Congress 2017 – GR4 Clinical Grand Round: always the same, really?
Year: 2017

What do we need from our patients? - the clinician's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014

The patient is fighting the ventilator: how to assess and solve the problem
Source: ERS Course 2018 - Noninvasive ventilation: advanced
Year: 2018